Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting

被引：0
|
作者：
Sadetsky, N. [1 ]
Corvino, F. [2 ]
Surinach, A. [2 ]
Goodman, G. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Genesis Res LLC, Hoboken, NJ USA
来源：
MELANOMA RESEARCH | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P062
引用
下载
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [31] Liraglutide Effectiveness in Real-World Clinical Setting in Croatia
    Berkovic, Maja Cigrovski
    Bilic-Curcic, Ines
    Gradiser, Marina
    Mahecic, Davorka Herman
    Grgurevic, Miaden
    DIABETES, 2017, 66 : A298 - A298
  • [32] Initial experience with teriflunomide in a real-world clinical setting
    Duquette, P.
    Roger, E.
    Nadeau, N.
    Hum, S.
    Bigras, C.
    Despault, P.
    Lapierre, Y.
    Grand'Maison, F.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 243 - 243
  • [33] Impact of Natalizumab on Economic and Clinical Outcomes in MS Patients in the Real-World Setting
    Cai, Qian
    Tan, Hiangkiat
    Agarwal, Sonalee
    Kamat, Siddhesh
    NEUROLOGY, 2010, 74 (09) : A65 - A65
  • [34] Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting
    Zanichelli, Andrea
    Longhurst, Hilary J.
    Maurer, Marcus
    Bouillet, Laurence
    Aberer, Werner
    Fabien, Vincent
    Andresen, Irmgard
    Caballero, Teresa
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (04) : 394 - 398
  • [35] Baseline characteristics of patients enrolled in LEMQoL, a study assessing health-related quality of life in RRMS patients treated with alemtuzumab in a real-world clinical setting
    Van Wijmeersch, B.
    Patti, F.
    Hobart, J.
    Kizlaitiene, R.
    Vanderdonckt, P.
    Shor, S.
    Andreasen, A. K.
    Uitdehaag, B. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 866 - 866
  • [36] Real-world dosing, management, and clinical outcomes of patients (pts) with metastatic pancreatic adenocarcinoma (mPDAC) treated with liposomal irinotecan.
    Abushahin, Laith, I
    Cockrum, Paul
    Surinach, Andy
    Belanger, Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting
    Bessette, Louis
    Kapur, Suneil
    Zummer, Michel
    Starr, Michael
    Choquette, Denis
    Sheriff, Maqbool
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1197 - 1197
  • [38] Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting
    Fonseca, Eduardo
    Iglesias, Raquel
    Paradela, Sabela
    Fernandez-Torres, Rosa M.
    Elberdin, Laida
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (03) : 217 - 222
  • [39] Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting
    Pedersen, Sidsel
    Larsen, Kirstine Ostenfeld
    Christensen, Alex Horby
    Svane, Inge Marie
    Zerahn, Bo
    Ellebaek, Eva
    ACTA ONCOLOGICA, 2022, 61 (01) : 45 - 51
  • [40] Clinical characteristics and sick leave associated with infectious mononucleosis in a real-world setting in Germany
    Kap, Elisabeth J.
    Konrad, Marcel
    Kostev, Karel
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021,
12345